REFERENCES
1. Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a nonreferral-based population. J Am Vet Med Assoc 1995;206(11):1721-1728.
2. Berendt M, Gram L. Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology. J Vet Intern Med 1999;13(1):14-20.
3. Lane SB, Bunch SE. Medical management of recurrent seizures in dogs and cats. J Vet Intern Med 1990;4(1):26-39.
4. Podell M. Seizures in dogs. Vet Clin North Am Small Anim Pract 1996;26(4):779-809.
5. Ruehlmann D, Podell M, March P. Treatment of partial seizures and seizure-like activity with felbamate in six dogs. J Small Anim Pract 2001;42(8):403-408.
6. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1998;28(2):411-448.
7. Dayrell Hart B, Tiches D, Vite C, et al. Efficacy and safety of felbamate as an anticonvulsant in dogs with refractory seizures
(abst). J Vet Intern Med 1996;10:174.
8. Platt SR, Adams V, Garosi LS, et al. Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Vet Rec 2006;159(26):881-884.
9. Govendir M, Perkins M, Malik R. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive
agent. Aust Vet J 2005;83(10):602-608.
10. Dunayer EK, Gwaltney-Brant SM. Acute hepatic failure and coagulopathy associated with xylitol ingestion in eight dogs. J Am Vet Med Assoc 2006;229(7):1113-1117.
11. Dewey CW, Cerda-Gonzalez S, Levine JM, et al. Pregabalin therapy for refractory idiopathic epilepsy in dogs (abst). J Vet Intern Med 2008;22:765.
12. Orito K, Saito M, Fukunaga K, et al. Pharmacokinetics of zonisamide and drug interaction with phenobarbital in dogs. J Vet Pharmacol Ther 2008;31(3):259-264.
13. Dewey CW, Guiliano R, Boothe DM, et al. Zonisamide therapy for refractory idiopathic epilepsy in dogs. J Am Anim Hosp Assoc 2004;40(4):285-291.
14. von Klopmann T, Rambeck B, Tipold A. Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs.
J Small Anim Pract 2007;48(3):134-138.
15. Volk HA, Matiasek LA, Reliu-Pascual AL, et al. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic
dogs. Vet J 2008;176(3):310-319.
16. Patterson EE, Goel V, Cloyd JC, et al. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
J Vet Pharmacol Ther 2008;31(3):253-258.
17. Burneo JG, Montori VM, Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav 2002;3(6):532-534.
|